Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Komal Plouffe"'
Autor:
Scott A. Tomlins, Nickolay A. Khazanov, Benjamin J. Bulen, Daniel H. Hovelson, Melissa J. Shreve, Laura E. Lamb, Marc R. Matrana, Mark E. Burkard, Eddy Shih-Hsin Yang, William Jeffery Edenfield, E. Claire Dees, Adedayo A. Onitilo, Michael Thompson, Gary L. Buchschacher, Alan M. Miller, Alexander Menter, Benjamin Parsons, Timothy Wassenaar, Leon C. Hwang, J. Marie Suga, Robert Siegel, William Irvin, Suresh Nair, Jennifer N. Slim, Jamal Misleh, Jamil Khatri, Gregory Masters, Sachdev Thomas, Malek Safa, Daniel M. Anderson, Kat Kwiatkowski, Khalis Mitchell, Tina Hu-Seliger, Stephanie Drewery, Andrew Fischer, Komal Plouffe, Eric Czuprenski, Jennifer Hipp, Travis Reeder, Hana Vakil, D. Bryan Johnson, Daniel R. Rhodes
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-14 (2023)
Tomlins et al. develop an Immunotherapy Response Score (IRS) to predict clinical benefit from checkpoint inhibition across solid tumors. IRS integrates TMB and gene expression, is evaluable from FFPE material, and is predictive for real-world progres
Externí odkaz:
https://doaj.org/article/4592ab4c5780454fabd8956daa3f8f79
Autor:
Udit Singhal, Srinivas Nallandhighal, Jeffrey Tosoian, Trinh Pham, Judith Stangl-Kremser, CJ Lui, Razeem Karim, Komal Plouffe, Todd Morgan, Marcin Cieslik, Roberta Luciano, Shahrokh Shariat, Nadia Finocchio, Lucia Dambrosio, Claudio Doglioni, Arul Chinnaiyan, Scott Tomlins, Alberto Briganti, Ganesh Palapattu, Aaron Udager, Simpa Salami
Localized prostate cancer is composed of multiple spatially distinct tumors with significant inter- and intra-tumoral molecular heterogeneity. This genomic diversity gives rise to many competing subclones that may drive the biological trajectory of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ba28c5b75332a546b789eddc1968436
https://doi.org/10.21203/rs.3.rs-2786222/v1
https://doi.org/10.21203/rs.3.rs-2786222/v1